Philogen
€22.20Change from previous close: −0.45%Absolute change: −€0.10
At a glance
- Revenue growth
- +324.79%
- 2025 vs 2024
- Net income growth
- +407.10%
- 2025 vs 2024
- Net margin
- 73.1%
- 2024: 61.2%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 314 | 74.0 | 23.1 | 23.7 |
| Cost of revenue | 5.3 | 3.1 | 3.5 | 2.9 |
| Gross profit | 309 | 70.9 | 19.7 | 20.9 |
| Selling, general and administrative | 12.7 | 2.4 | 2.5 | 2.4 |
| Research and development | 3.4 | 2.2 | 3.5 | 1.9 |
| Operating income | 258 | 38.3 | -8.3 | 0.8 |
| EBIT | 260 | 40.9 | -5.6 | -4.0 |
| EBITDA | 265 | 44.8 | -2.0 | -1.2 |
| Interest expense | 0.4 | 0.5 | 0.5 | 0.4 |
| Pre-tax income | 260 | 40.4 | -6.2 | -4.4 |
| Income tax | 30.4 | -4.9 | -0.0 | 1.0 |
| Net income | 230 | 45.3 | -6.2 | -5.4 |
| Net income to common shareholders | 230 | 45.3 | -6.2 | -5.4 |
| Basic EPS | 5.70 | 1.12 | -0.15 | -0.13 |
| Diluted EPS | 5.70 | 1.12 | -0.15 | -0.13 |
| Average shares (basic) | 40.3 | 40.3 | 40.2 | 40.6 |
| Average shares (diluted) | 40.3 | 40.3 | 40.2 | 40.6 |